Variant report
Variant | esv3520873 |
---|---|
Chromosome Location | chr19:51257299-51267138 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:152)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF3 | chr19:51263161-51263447 | K562 | blood: | n/a | n/a |
2 | ATF3 | chr19:51263192-51263431 | GM12878 | blood: | n/a | n/a |
3 | ATF3 | chr19:51263137-51263443 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | CBX3 | chr19:51263013-51263594 | K562 | blood: | n/a | n/a |
5 | CEBPB | chr19:51263182-51263643 | A549 | lung: | n/a | chr19:51263448-51263459 |
6 | CEBPB | chr19:51263101-51263642 | A549 | lung: | n/a | chr19:51263448-51263459 |
7 | CEBPB | chr19:51263261-51263636 | HepG2 | liver: | n/a | chr19:51263448-51263459 |
8 | CEBPB | chr19:51263175-51263636 | Hela-S3 | cervix: | n/a | chr19:51263448-51263459 |
9 | CEBPB | chr19:51264181-51264359 | K562 | blood: | n/a | n/a |
10 | CEBPB | chr19:51263228-51263684 | A549 | lung: | n/a | chr19:51263448-51263459 |
11 | CEBPB | chr19:51263279-51263520 | ECC-1 | luminal epithelium: | n/a | chr19:51263448-51263459 |
12 | CEBPB | chr19:51266871-51267131 | K562 | blood: | n/a | n/a |
13 | CEBPB | chr19:51263226-51263641 | H1-hESC | embryonic stem cell: | n/a | chr19:51263448-51263459 |
14 | CEBPB | chr19:51263204-51263640 | MCF-7 | breast: | n/a | chr19:51263448-51263459 |
15 | CEBPB | chr19:51263149-51263649 | K562 | blood: | n/a | chr19:51263448-51263459 |
16 | CEBPB | chr19:51263262-51263640 | IMR90 | lung: | n/a | chr19:51263448-51263459 |
17 | CEBPB | chr19:51263273-51263642 | ECC-1 | luminal epithelium: | n/a | chr19:51263448-51263459 |
18 | CEBPB | chr19:51263301-51263537 | K562 | blood: | n/a | chr19:51263448-51263459 |
19 | CEBPB | chr19:51263143-51263622 | K562 | blood: | n/a | chr19:51263448-51263459 |
20 | CEBPB | chr19:51266996-51267088 | K562 | blood: | n/a | n/a |
21 | CEBPB | chr19:51263161-51263648 | MCF-7 | breast: | n/a | chr19:51263448-51263459 |
22 | CHD2 | chr19:51263138-51263480 | H1-hESC | embryonic stem cell: | n/a | n/a |
23 | CHD2 | chr19:51263145-51263466 | K562 | blood: | n/a | n/a |
24 | CTCF | chr19:51259442-51259509 | GM20000 | blood: | n/a | n/a |
25 | CTCF | chr19:51265892-51265951 | GM20000 | blood: | n/a | n/a |
26 | CTCF | chr19:51259702-51259707 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | CTCF | chr19:51259665-51259695 | H1-hESC | embryonic stem cell: | n/a | n/a |
28 | EGR1 | chr19:51265351-51265495 | K562 | blood: | n/a | n/a |
29 | EGR1 | chr19:51265307-51265507 | K562 | blood: | n/a | n/a |
30 | ELF1 | chr19:51263226-51263485 | GM12878 | blood: | n/a | n/a |
31 | ELF1 | chr19:51263221-51263490 | K562 | blood: | n/a | n/a |
32 | ELF1 | chr19:51263195-51263521 | SK-N-SH | brain: | n/a | n/a |
33 | ELF1 | chr19:51263104-51263493 | A549 | lung: | n/a | n/a |
34 | ELF1 | chr19:51263160-51263539 | MCF-7 | breast: | n/a | n/a |
35 | ELF1 | chr19:51263096-51263583 | K562 | blood: | n/a | n/a |
36 | ELF1 | chr19:51263180-51263554 | A549 | lung: | n/a | n/a |
37 | ELF1 | chr19:51262976-51263639 | HCT-116 | colon: | n/a | n/a |
38 | EP300 | chr19:51263177-51263465 | K562 | blood: | n/a | n/a |
39 | ETS1 | chr19:51263096-51263444 | A549 | lung: | n/a | n/a |
40 | ETS1 | chr19:51263085-51263506 | A549 | lung: | n/a | n/a |
41 | FOS | chr19:51265160-51265314 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | FOS | chr19:51263139-51263507 | K562 | blood: | n/a | n/a |
43 | FOXA2 | chr19:51262281-51262789 | A549 | lung: | n/a | n/a |
44 | GATA2 | chr19:51266853-51267081 | SH-SY5Y | brain: | n/a | n/a |
45 | HCFC1 | chr19:51263086-51263540 | K562 | blood: | n/a | n/a |
46 | HCFC1 | chr19:51262953-51263595 | Hela-S3 | cervix: | n/a | n/a |
47 | IRF1 | chr19:51263115-51263527 | K562 | blood: | n/a | n/a |
48 | IRF1 | chr19:51263147-51263495 | K562 | blood: | n/a | n/a |
49 | IRF3 | chr19:51263211-51263348 | GM12878 | blood: | n/a | n/a |
50 | JUN | chr19:51264215-51264327 | K562 | blood: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
GPR32P1 | TF binding region |
ENSG00000268375 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs372095449 | chr19:51257380-51257381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186856883 | chr19:51257381-51257382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs567746749 | chr19:51257388-51257389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs113877702 | chr19:51257416-51257417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374198358 | chr19:51257425-51257426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs376008556 | chr19:51257431-51257432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs578003250 | chr19:51257432-51257433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs574086500 | chr19:51257461-51257462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs369550994 | chr19:51257462-51257463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs73044695 | chr19:51257463-51257464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs558038986 | chr19:51257465-51257466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs569460719 | chr19:51257529-51257530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561992633 | chr19:51257530-51257531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs75450866 | chr19:51257542-51257543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553718417 | chr19:51257591-51257592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575807082 | chr19:51257596-51257597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs139138526 | chr19:51257635-51257636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561571516 | chr19:51257650-51257651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs117311430 | chr19:51257679-51257680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs150016774 | chr19:51257721-51257722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73044697 | chr19:51257733-51257734 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs532944133 | chr19:51257788-51257789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551758951 | chr19:51257789-51257790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs116703061 | chr19:51257828-51257829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs35014432 | chr19:51257835-51257836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs117272185 | chr19:51257857-51257858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192430902 | chr19:51257959-51257960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144284016 | chr19:51257968-51257969 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
29 | rs185804650 | chr19:51257972-51257973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535114382 | chr19:51257985-51257986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112894840 | chr19:51257993-51257994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189929831 | chr19:51258000-51258001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs116826505 | chr19:51258011-51258012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557736087 | chr19:51258091-51258092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs527986814 | chr19:51258106-51258107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560033973 | chr19:51258134-51258135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143542589 | chr19:51258139-51258140 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs146878436 | chr19:51258148-51258149 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs193194170 | chr19:51258156-51258157 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs62114263 | chr19:51258159-51258160 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs111881027 | chr19:51258162-51258163 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs528881180 | chr19:51258167-51258168 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs58220021 | chr19:51258181-51258182 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs144420630 | chr19:51258215-51258216 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs544973248 | chr19:51258225-51258226 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs113713550 | chr19:51258258-51258259 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs112757047 | chr19:51258266-51258267 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs531229054 | chr19:51258288-51258289 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs563512067 | chr19:51258290-51258291 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs188362423 | chr19:51258295-51258296 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17160897 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
Lung cancer | 18438408 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:51243800-51261600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr19:51252200-51263000 | Weak transcription | K562 | blood |
3 | chr19:51258800-51260200 | Enhancers | Placenta | Placenta |
4 | chr19:51260200-51261600 | Weak transcription | Placenta | Placenta |
5 | chr19:51261600-51261800 | Strong transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr19:51261600-51268000 | Enhancers | Placenta | Placenta |
7 | chr19:51261800-51262000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr19:51261800-51262000 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr19:51262000-51262200 | Strong transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr19:51262000-51263000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr19:51262200-51273800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr19:51263000-51263200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr19:51263000-51264600 | Enhancers | K562 | blood |
14 | chr19:51264600-51269000 | Weak transcription | K562 | blood |
15 | chr19:51265800-51266000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
16 | chr19:51266000-51267000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr19:51266600-51267000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
18 | chr19:51267000-51267400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
19 | chr19:51267000-51267400 | Flanking Active TSS | Fetal Adrenal Gland | Adrenal Gland |
20 | chr19:51267000-51267600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |